Filing Details

Accession Number:
0001213900-21-064007
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-07 18:44:35
Reporting Period:
2021-12-06
Accepted Time:
2021-12-07 18:44:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410098 Cormedix Inc. CRMD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1811612 T Matthew David C/O Cormedix Inc. 300 Connell Drive
Suite 4200
Berkeley Heights NJ 07922
Interim Ceo And Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-06 1,000 $4.50 3,150 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy Common Stock) $5.56 2031-11-01 125,000 125,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $8.32 2031-01-11 80,000 80,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $5.63 2030-05-11 125,000 125,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $4.08 2030-05-11 125,000 125,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2031-11-01 125,000 125,000 Direct
2031-01-11 80,000 80,000 Direct
2030-05-11 125,000 125,000 Direct
2030-05-11 125,000 125,000 Direct
Footnotes
  1. These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
  2. These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
  3. These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.